Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Phase II Trial of Bevacizumab in Persistent or Recurrent Epithelial Ovarian Cancer or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study

PaperCitations, authors & open-access status

Phase II Trial of Bevacizumab in Persistent or Recurrent Epithelial Ovarian Cancer or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 884 citations, 2007 year and bronze oa status.

884
Citations
2007
Year
bronze
OA Status

Related on ScholarIQ

Robert A. Burger
Author
Bradley J. Monk
Author
Journal of Clinical Oncology
Journal
Ovarian cancer diagnosis and treatment
Topic
Ovarian cancer diagnosis and treatment
Topic
Intraperitoneal and Appendiceal Malignancies
Topic
470M+ articles · free account